CSF NfL levels are increased in CLN2 disease patients with lower levels observed in patients with an atypical phenotype therefore Nfl levels potentially indicate disease progression and show the effect of treatment with Brineura, correlating with the decline of neuroaxonal damage to very low levels after 2.8 years of ERT. This evidence concerns the gene NEFL and glycogen storage disease VI.